Literature DB >> 15172102

Exclusion of CYP46 and APOM as candidate genes for Alzheimer's disease in a French population.

Amro Kabbara1, Nathalie Payet, Dominique Cottel, Bernard Frigard, Philippe Amouyel, Jean-Charles Lambert.   

Abstract

Alzheimer's disease (AD) is a complex, multifactorial disorder, probably resulting from an interaction between environmental and genetic factors. Increasing evidence points to a link between cholesterol turnover and AD, suggesting that genes implicated in brain cholesterol homeostasis may be potential candidate genes for AD. With this background, we tested the potential association of the CYP46, APOM and APOF genes with the risk of developing AD. CYP46 encodes the enzyme cholesterol 24-hydrolase, which plays a key role in brain cholesterol turnover, and APOF and APOM encode apolipoproteins belonging to the large lipocalin family, which also includes ApoE. In contrast to two previous reports but in accordance with one other, we were unable to detect an association between an intron 2 polymorphism of CYP46 and AD. We also searched for polymorphisms within the APOM and APOF by dHPLC. We were unable to detect any polymorphisms in the coding and exon/intron sequences of the APOF. Finally, we excluded APOM as a genetic determinant of AD in our large French case control population.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15172102     DOI: 10.1016/j.neulet.2004.03.066

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  9 in total

1.  CYP46 T/C polymorphism is not associated with Alzheimer's dementia in a population from Hungary.

Authors:  Anna Juhász; Agnes Rimanóczy; Krisztina Boda; Gábor Vincze; Gyozo Szlávik; Marianna Zana; Annamária Bjelik; Magdolna Pákáski; Nikoletta Bódi; András Palotás; Zoltán Janka; János Kálmán
Journal:  Neurochem Res       Date:  2005-08       Impact factor: 3.996

2.  A pilot study of gene/gene and gene/environment interactions in Alzheimer disease.

Authors:  Nader Ghebranious; Bickol Mukesh; Philip F Giampietro; Ingrid Glurich; Susan F Mickel; Stephen C Waring; Catherine A McCarty
Journal:  Clin Med Res       Date:  2010-08-03

3.  An intronic CYP46A1 polymorphism is associated with Alzheimer disease in a Chinese Han population.

Authors:  Xiao-ming He; Zhen-xin Zhang; Jun-Wu Zhang; Yong-tao Zhou; Cheng-bin Wu; Mou-ni Tang; Zhen Hong
Journal:  J Mol Neurosci       Date:  2012-04-22       Impact factor: 3.444

4.  Determination of single-nucleotide polymorphism in the proximal promoter region of apolipoprotein M gene in coronary artery diseases.

Authors:  Lu Zheng; Guanghua Luo; Xiaoying Zhang; Jun Zhang; Jiang Zhu; Jiang Wei; Qinfeng Mu; Lujun Chen; Peter Nilsson-Ehle; Ning Xu
Journal:  Int J Gen Med       Date:  2009-12-29

Review 5.  CYP46A1 T/C polymorphism associated with the APOE ε4 allele increases the risk of Alzheimer's disease.

Authors:  Ling Li; Zegang Yin; Juan Liu; Gongbo Li; Yanjiang Wang; Jiachuan Yan; Huadong Zhou
Journal:  J Neurol       Date:  2012-10-16       Impact factor: 4.849

Review 6.  Cyp46 polymorphisms in Alzheimer's disease: a review.

Authors:  Anália Nusya Medeiros Garcia; Maria Tereza Cartaxo Muniz; Hugo Rafael Souza e Silva; Helker Albuquerque da Silva; Luiz Athayde-Junior
Journal:  J Mol Neurosci       Date:  2009-08-25       Impact factor: 3.444

7.  Prognostic transcriptional association networks: a new supervised approach based on regression trees.

Authors:  Isabel Nepomuceno-Chamorro; Francisco Azuaje; Yvan Devaux; Petr V Nazarov; Arnaud Muller; Jesús S Aguilar-Ruiz; Daniel R Wagner
Journal:  Bioinformatics       Date:  2010-11-21       Impact factor: 6.937

8.  Association study of cholesterol-related genes in Alzheimer's disease.

Authors:  M Axel Wollmer; Kristel Sleegers; Martin Ingelsson; Cezary Zekanowski; Nathalie Brouwers; Aleksandra Maruszak; Fabienne Brunner; Kim-Dung Huynh; Lena Kilander; Rose-Marie Brundin; Marie Hedlund; Vilmantas Giedraitis; Anna Glaser; Sebastiaan Engelborghs; Peter P De Deyn; Elisabeth Kapaki; Magdalini Tsolaki; Makrina Daniilidou; Dimitra Molyva; George P Paraskevas; Dietmar R Thal; Maria Barcikowska; Jacek Kuznicki; Lars Lannfelt; Christine Van Broeckhoven; Roger M Nitsch; Christoph Hock; Andreas Papassotiropoulos
Journal:  Neurogenetics       Date:  2007-03-27       Impact factor: 3.017

9.  Apolipoprotein M.

Authors:  Guanghua Luo; Xiaoying Zhang; Peter Nilsson-Ehle; Ning Xu
Journal:  Lipids Health Dis       Date:  2004-10-04       Impact factor: 3.876

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.